Perrigo Company (PRGO), Elan Corporation, plc (ADR) (ELN), Johnson & Johnson (JNJ): Is This Health Care Stock Underrated?
Shares of Perrigo Company (NYSE:PRGO), one of the world's largest health care suppliers, slid with the broader market on Aug.
Posts Tagged ‘GlaxoSmithKline plc (GSK)’
GlaxoSmithKline plc (ADR) (GSK), Sarepta Therapeutics Inc (SRPT): Could This DMD Treatment Become a Blockbuster Drug?
Duchenne muscular dystrophy, or DMD, is a muscle-wasting disease caused by a genetic mutation in the dystrophin gene -- the largest gene on the X chromosome -- which affects one...
ChemoCentryx Inc (CCXI), GlaxoSmithKline plc (ADR) (GSK): Horrendous Health-Care Stocks This Week
While many investors worried about the Nasdaq's three-hour shutdown this week, shareholders of a few stocks probably wished it wouldn't have come back up.
GlaxoSmithKline plc (ADR) (GSK), Johnson & Johnson (JNJ): ChemoCentryx Inc (CCXI) Collapses on Crohn’s Disease Results
Shares of small biotech ChemoCentryx Inc (NASDAQ:CCXI) collapsed by 44% in early trading on Friday before paring the losses somewhat.
Gilead Sciences, Inc. (GILD), GlaxoSmithKline plc (ADR) (GSK): The Past, Present, and Future of HIV Treatments
HIV, the virus that causes AIDS, has become one of the world's most devastating diseases since it was first recognized more than three decades ago.
Valeant Pharmaceuticals Intl Inc (VRX), GlaxoSmithKline plc (ADR) (GSK) – CAPScall of the Week: Raptor Pharmaceutical Corp. (RPTP)
For years, satirical late-night TV host Stephen Colbert has been running a series on his show called "Better Know a District," which highlights one of the 435 U.S.
GlaxoSmithKline plc (ADR) (GSK), Gilead Sciences, Inc. (GILD): Did Sarepta Therapeutics Inc (SRPT) Just Knock Out Its DMD Competitor?
Ignore the bickering between shareholders of Sarepta Therapeutics Inc (NASDAQ:SRPT) and GlaxoSmithKline plc (ADR) (NYSE:GSK) /Prosensa for a moment, because these are exciting...
Osiris Therapeutics, Inc. (OSIR), GlaxoSmithKline plc (ADR) (GSK), Forest Laboratories, Inc. (FRX): This Week in Biotech
With the SPDR S&P Biotech Index up 34% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
GlaxoSmithKline plc (ADR) (GSK), Abbott Laboratories (ABT): China’s Murky Business Climate Won’t Clear Up Soon
A strong week for investors ended especially well in China, as Hong Kong's HANG SENG INDEX (INDEXHANGSENG:HSI) index jumped by 3.3% for the week.
Johnson & Johnson (JNJ), Express Scripts Holding Company (ESRX), Gilead Sciences, Inc. (GILD): Three Great Buy-and-Hold Health-Care Stocks
This could have been an enormously more difficult effort. I started out with the goal to identify the three best stocks in health care to buy and hold for years, even decades.
GlaxoSmithKline plc (ADR) (GSK), Sarepta Therapeutics Inc (SRPT): The Good and Bad of a Competitor’s Failure
On the surface, GlaxoSmithKline plc (ADR) (NYSE:GSK)'s release of phase 2 data on drisapersen looks like good news for Sarepta Therapeutics Inc (NASDAQ:SRPT)'s competing Duchenne...
GlaxoSmithKline plc (ADR) (GSK), Novartis AG (ADR) (NVS): This Company’s Debt Might Be a Concern
GlaxoSmithKline plc (ADR) (NYSE:GSK) has been accused of making illegal payments to Chinese doctors and government officials by siphoning them through travel agencies.
GlaxoSmithKline plc (ADR) (GSK), Merck & Co., Inc. (MRK): The 10 Most Common Reasons People Visit Their Doctor
With the full implementation of the individual portion of the Patient Protection and Affordable Care Act less than five months away, physicians and doctor's offices around the...
Arena Pharmaceuticals, Inc. (ARNA), VIVUS, Inc. (VVUS): Can the Newly Discovered Obesity Genes Help You Lose Weight?
Quite a few research papers published recently have shown that mutations in genes can control your appetite and your ability to burn calories.
GlaxoSmithKline plc (ADR) (GSK), Roche Holding Ltd. (ADR) (RHHBY): Why Alex Rodriguez Could Bring Big Business to This Sector
Baseball star Alex Rodriguez had an opportunity to be perhaps the greatest player of the past decade or even longer -- that was until he threw it all away by admitting to steroid...
Sanofi SA (ADR) (SNY), GlaxoSmithKline plc (ADR) (GSK): This Company Is Tackling Multiple Sclerosis Head On
Currently existing immunomodulatory drugs that treat Multiple Sclerosis only work to treat relapse or attacks, manage symptoms, or modify the course of the disease.
Pfizer Inc. (PFE), Amgen, Inc. (AMGN): The Best-Selling Medications of 2013 (So Far)
Believe it or not, 2013 is getting close to being two-thirds of the way over. Many pharmaceutical firms have enjoyed great stock returns and nice profits thus far in the year.
Array Biopharma Inc (ARRY), AstraZeneca plc (ADR) (AZN), GlaxoSmithKline plc (ADR) (GSK): This Cancer Biotech Is Looking for Other Green Pastures
Array Biopharma Inc (NASDAQ:ARRY), a biotech company primarily focused on discovery of drugs for cancer treatment, is making forays into the asthma market.
Theravance Inc (THRX), GlaxoSmithKline plc (ADR) (GSK): Which of These COPD Treatments Will Come Out on Top?
To most people, cigarettes are often associated with lung cancer.
Why GlaxoSmithKline plc (ADR) (GSK) Will Survive the China Scandal
GlaxoSmithKline plc (ADR) (NYSE:GSK) has been accused of the violation of Chinese laws wherein the company’s key officials have used around 700 agencies and firms for increasing...
Array Biopharma Inc (ARRY), InterMune Inc (ITMN): Three Humongous Health-Care Stocks This Week
The study included 184 patients with mild-to-moderate persistent allergic asthma.
GlaxoSmithKline plc (ADR) (GSK), Novo Nordisk A/S (ADR) (NVO): China’s Growth Crisis Swings Into High Gear
It's been a long time since China's double-digit economic growth became the envy of nations across the world. Since then, the Chinese economy has slowed.
Sarepta Therapeutics Inc (SRPT) Moves Ahead With Seeking Eteplirsen Approval: Hip, Hip, Uh-Oh?
Investors wondered for months if Sarepta Therapeutics Inc (NASDAQ:SRPT) would pursue accelerated approval for Duchenne muscular dystrophy, or DMD, drug eteplirsen.
Unilever plc (ADR) (UL), GlaxoSmithKline plc (ADR) (GSK), Vodafone Group Plc (ADR) (VOD): Why Investors Should Consider These Fantastic English Stocks
Diversification is a subject most investors understand well.
Pfizer Inc. (PFE), GlaxoSmithKline plc (ADR) (GSK): Three Healthcare Stocks for Growth and Dividends
The healthcare sector has been one of the best sectors for dividend hunters -- most of the companies operating in the sector generate massive cash flow and payout a large chunk...
Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), GlaxoSmithKline plc (ADR) (GSK) – Hold On to Your Hair: Three Leading Treatments for Male Pattern Baldness
By age 35, around two-thirds of all American men will have begun to experience androgenetic alopecia, more commonly known as male pattern baldness.
Pfizer Inc. (PFE), Merck & Co., Inc. (MRK): The Five Most Misdiagnosed Diseases
There's little denying that the technological, research, and medicinal aspects of patient care are improving at breakneck speed.
GlaxoSmithKline plc (ADR) (GSK), Pfizer Inc. (PFE), Merck & Co., Inc. (MRK): These Biotech Companies Are Facing Setbacks, but Investors Shouldn’t Worry
Most recently, executives working for the U.K.-based GlaxoSmithKline plc (ADR) (NYSE:GSK) in China have been accused of, and confessed to, serious corruption and tax-related ...
What Does Celgene Corporation (CELG)’s Failed Trial Mean for Investors?
Early this morning, Celgene Corporation (NASDAQ:CELG) announced that it was discontinuing the phase 3 ORIGIN Trial evaluating Revlimid (lenalidomide) in B-Cell chronic lymphomatic...
GlaxoSmithKline plc (ADR) (GSK), Theravance Inc (THRX), Pfizer Inc. (PFE): 3 Potential Game Changers for COPD
Over 13 million Americans have it. More than 120,000 of them die every year.
VIVUS, Inc. (VVUS), Merck & Co., Inc. (MRK): What’s Your Biggest Fear? The Answer Might Scare You!
With all of the factors we have to worry about in our everyday lives, it is somewhat a wonder that we're not only able to survive, but thrive, as a society.
Prosensa Holding BV (RNA), WebMD Health Corp. (WBMD): Three Humongous Health-Care Stocks This Week
If you thought the fireworks ended after the Fourth of July celebrations last week, think again.
Sarepta Therapeutics Inc (SRPT): Is The DMD Market Becoming Too Crowded?
A year ago, AVI BioPharma underwent a process from being an $85 million biotechnology company to a $1.3 billion company called Sarepta Therapeutics Inc (NASDAQ:SRPT).
Merck & Co., Inc. (MRK), GlaxoSmithKline plc (ADR) (GSK): Shot of Good News for This Vaccine Maker
The Centers for Disease Control recently released a study showing that the introduction of human papillomavirus vaccines has significantly reduced infection rates among teenaged...
Could This Safe Play Help Eli Lilly & Co. (LLY)?
At the American Diabetes Association meeting last month, Eli Lilly & Co. (NYSE:LLY) presented promising data for the GLP-1 agonist dulaglutide.
Drug Deal Can Only Help VIVUS, Inc. (VVUS) So Much
VIVUS, Inc. (NASDAQ:VVUS) has found an Italian to help it out.
Could This Safe Play Help Eli Lilly & Co. (LLY)?
At the American Diabetes Association meeting last month, Eli Lilly & Co. (NYSE:LLY) presented promising data for the GLP-1 agonist dulaglutide.
Amarin Corporation plc (ADR) (AMRN) Shares Sink on Secondary Offering
"More means less." Amarin Corporation plc (ADR) (NASDAQ:AMRN) demonstrated this seemingly contradictory maxim today following its announcement of a new public offering.
Arena Pharmaceuticals, Inc. (ARNA): 1 Biotech You Might Want to Explore Right Now!
After more than a year, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)’ weight-loss drug Belviq has finally launched.
Onyx Pharmaceuticals, Inc. (ONXX), Achillion Pharmaceuticals, Inc. (ACHN): This Week in Biotech
With the SPDR S&P Biotech Index up 20% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Gilead Sciences, Inc. (GILD), Johnson & Johnson (JNJ): Is a Breakthrough Treatment on the Way for People With HIV?
We as a country have a come a long way over the past two decades with regard to treating HIV and reducing the number of AIDS diagnoses.
GlaxoSmithKline plc (ADR) (GSK): Why You Should Buy This European Healthcare Company
Investors who buy stock in the major pharmaceutical companies likely do so because of several factors, including steady growth, modest valuations, and high dividend yields.
AstraZeneca plc (ADR) (AZN), PDL BioPharma Inc. (PDLI): Tempting Healthcare Dividend Stocks to Avoid
When screening for health-care dividend stocks, it's tempting to look for the ones with the highest yield.
Arena Pharmaceuticals, Inc. (ARNA), VIVUS, Inc. (VVUS): One Weight-Loss Drug That Investors Forgot
You know Belviq and Qsymia and Contrave and Empatic, but do you recall the still most widely used weight-loss drug of all? It seems almost like ancient history now, but back in...
GlaxoSmithKline plc (ADR) (GSK), Bristol Myers Squibb Co. (BMY), Merck & Co., Inc. (MRK): If You Are an Income Investor, You Will Love These Pharma Companies
Companies know that to attract regular income-seeking investors, it helps to pay out high dividends.
Johnson & Johnson (JNJ), Sanofi SA (ADR) (SNY): Health Care Investment Ideas From Warren Buffett
Famed investor Warren Buffett once called the high cost of health care a "tapeworm eating at our economic body." While he might be disgusted by the costs, it hasn't stopped ...
Pfizer Inc. (PFE), VIVUS, Inc. (VVUS): Cheap Viagra That Americans Can’t Buy
Cheap generic versions of Pfizer Inc. (NYSE:PFE)'s Viagra are coming to Europe, according the generic-drug maker Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA).
Oncolytics Biotech, Inc. (USA) (ONCY): This High-Risk, High-Reward Biotech Is Worth a Look
Let me preface this by saying that investing in the biotech sector can sometimes be nothing more than speculating.
